Clinical Trials Directory

Trials / Unknown

UnknownNCT02522000

Functional Dyspepsia and Symptom Perception

Symptom Perception in Patients With Functional Dyspepsia: Involvement of the TRPV-1 Neuropeptide Pathway

Status
Unknown
Phase
Study type
Observational
Enrollment
70 (estimated)
Sponsor
Maastricht University Medical Center · Academic / Other
Sex
All
Age
18 Years – 65 Years
Healthy volunteers
Accepted

Summary

Functional dyspepsia (FD) is a heterogeneous disorder with multifactorial pathophysiology. Patients with FD have visceral hypersensitivity to mechanical and chemical stimuli. Several previous studies have described an increased chemosensitivity to oral capsaicin ingestion. Capsaicin is a natural agonist of TRPV-1 receptors present on afferent sensory neurons. Activation of the TRPV-1 receptor by capsaicin or other agonists results in the release of several neuropeptides (i.e. substance P, somatostatin). Besides, increased duodenal permeability and disruption of tight junction structure in FD patients compared to healthy volunteers has been reported in a recent study. In this observational study investigators will evaluate the role of the TRPV-1 neuropeptide pathway in patients with functional dyspepsia and healthy controls.

Conditions

Timeline

Start date
2015-07-01
Primary completion
2017-07-01
Completion
2017-07-01
First posted
2015-08-13
Last updated
2015-08-13

Locations

3 sites across 1 country: Netherlands

Source: ClinicalTrials.gov record NCT02522000. Inclusion in this directory is not an endorsement.

Functional Dyspepsia and Symptom Perception (NCT02522000) · Clinical Trials Directory